Skip to main content
Top
Published in: Skeletal Radiology 7/2015

01-07-2015 | Scientific Article

Improvement of diagnostic confidence for detection of multiple myeloma involvement of the ribs by a new CT software generating rib unfolded images: Comparison with 5- and 1-mm axial images

Authors: Georg Homann, Katja Weisel, Deedar Farhad Mustafa, Hendrik Ditt, Konstantin Nikolaou, Marius Horger

Published in: Skeletal Radiology | Issue 7/2015

Login to get access

Abstract

Objective

To investigate the performance of a new CT software generating rib unfolded images for improved detection of rib osteolyses in patients with multiple myeloma.

Materials and methods

One hundred sixteen patients who underwent whole-body reduced-dose multidetector computed tomography (WBRD-MDCT) for multiple myeloma diagnosis and during follow-up were retrospectively evaluated. Nonenhanced CT scans with 5- and 1-mm slice thickness were interpreted by two readers with focus on detection of rib involvement (location, number, fracture). Image analysis of “unfolded,” 1-mm-based CT rib images was subsequently undertaken. We classified the number of lytic bone lesions into 0, 1, 2, <5, <10 and ≥10. For all three data sets the reading time was registered.

Results

An approximated sum of 6,727 myeloma-related rib lesions was found. On a patient-based analysis, CT (5 mm), CT (1 mm) and CT (1 mm “unfolded rib”) yielded a sensitivity, specificity and accuracy of 79.7/94.7/87.1, 88.1/93/90.5 and 98.3/96.5/97.4, respectively. In a lesion-based analysis, the sensitivity, specificity and accuracy of the three evaluations were 69.7/87.2/70.5, 79.8/55.9/78 and 96.5/89.7/96.1. Mean reading time for 5 mm/1 mm axial images and unfolded images was 178.7/215.1/90.8 s, respectively.

Conclusion

The generation of “unfolded rib” images improves detection of rib involvement in patients with multiple myeloma and significantly reduces reading time.
Literature
1.
go back to reference Nanni C, Zamagni E, Farsad M, Castellucci P, Tosi P, Cangini D, et al. Role of 18 F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results. Eur J Nucl Med Mol Imaging. 2006;33(5):525–31.CrossRefPubMed Nanni C, Zamagni E, Farsad M, Castellucci P, Tosi P, Cangini D, et al. Role of 18 F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results. Eur J Nucl Med Mol Imaging. 2006;33(5):525–31.CrossRefPubMed
2.
go back to reference Terpos E, Dimopoulos MA. Myeloma bone disease: pathophysiology and management. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2005;16(8):1223–31.CrossRef Terpos E, Dimopoulos MA. Myeloma bone disease: pathophysiology and management. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2005;16(8):1223–31.CrossRef
3.
go back to reference Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78(1):21–33.CrossRefPubMed Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78(1):21–33.CrossRefPubMed
4.
go back to reference Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975;36(3):842–54.CrossRefPubMed Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975;36(3):842–54.CrossRefPubMed
5.
go back to reference Horger M, Kanz L, Denecke B, Vonthein R, Pereira P, Claussen CD, et al. The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma. Cancer. 2007;109(8):1617–26.CrossRefPubMed Horger M, Kanz L, Denecke B, Vonthein R, Pereira P, Claussen CD, et al. The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma. Cancer. 2007;109(8):1617–26.CrossRefPubMed
6.
go back to reference Horger M, Claussen CD, Bross-Bach U, Vonthein R, Trabold T, Heuschmid M, et al. Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography. Eur J Radiol. 2005;54(2):289–97.CrossRefPubMed Horger M, Claussen CD, Bross-Bach U, Vonthein R, Trabold T, Heuschmid M, et al. Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography. Eur J Radiol. 2005;54(2):289–97.CrossRefPubMed
7.
go back to reference Ippolito D, Besostri V, Bonaffini PA, Rossini F, Di Lelio A, Sironi S. Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM). Eur J Radiol. 2013;82(12):2322–7.CrossRefPubMed Ippolito D, Besostri V, Bonaffini PA, Rossini F, Di Lelio A, Sironi S. Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM). Eur J Radiol. 2013;82(12):2322–7.CrossRefPubMed
8.
go back to reference Wolf MB, Murray F, Kilk K, Hillengass J, Delorme S, Heiss C, et al. Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease. Eur J Radiol. 2014;83(7):1222–30.CrossRefPubMed Wolf MB, Murray F, Kilk K, Hillengass J, Delorme S, Heiss C, et al. Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease. Eur J Radiol. 2014;83(7):1222–30.CrossRefPubMed
9.
go back to reference Resnick D. Diagnosis of bone and joint disorders. 4th edn., WB Saunders Company Philadelphia. 2002. Resnick D. Diagnosis of bone and joint disorders. 4th edn., WB Saunders Company Philadelphia. 2002.
10.
go back to reference Lecouvet FE, Malghem J, Michaux L, Maldague B, Ferrant A, Michaux JL, et al. Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey. Br J Haematol. 1999;106(1):35–9.CrossRefPubMed Lecouvet FE, Malghem J, Michaux L, Maldague B, Ferrant A, Michaux JL, et al. Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey. Br J Haematol. 1999;106(1):35–9.CrossRefPubMed
11.
go back to reference Homann G, Mustafa DF, Ditt H, Spengler W, Kopp HG, Nikolaou K, et al. Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard F-FDG-PET/CT. Academic Radiology. 2015; e-published ahead of print; doi: 10.1016/j.acra.2014.12.005. Homann G, Mustafa DF, Ditt H, Spengler W, Kopp HG, Nikolaou K, et al. Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard F-FDG-PET/CT. Academic Radiology. 2015; e-published ahead of print; doi: 10.​1016/​j.​acra.​2014.​12.​005.
12.
go back to reference Princewill K, Kyere S, Awan O, Mulligan M. Multiple myeloma lesion detection with whole body CT versus radiographic skeletal survey. Cancer Invest. 2013;31(3):206–11.CrossRefPubMed Princewill K, Kyere S, Awan O, Mulligan M. Multiple myeloma lesion detection with whole body CT versus radiographic skeletal survey. Cancer Invest. 2013;31(3):206–11.CrossRefPubMed
13.
go back to reference Gleeson TG, Moriarty J, Shortt CP, Gleeson JP, Fitzpatrick P, Byrne B, et al. Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI). Skeletal Radiol. 2009;38(3):225–36.CrossRefPubMed Gleeson TG, Moriarty J, Shortt CP, Gleeson JP, Fitzpatrick P, Byrne B, et al. Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI). Skeletal Radiol. 2009;38(3):225–36.CrossRefPubMed
14.
go back to reference Horger M, Pereira P, Claussen CD, Kanz L, Vonthein R, Denecke B, et al. Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: correlation with haematological parameters. Br J Radiol. 2008;81(965):386–96.CrossRefPubMed Horger M, Pereira P, Claussen CD, Kanz L, Vonthein R, Denecke B, et al. Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: correlation with haematological parameters. Br J Radiol. 2008;81(965):386–96.CrossRefPubMed
15.
go back to reference Chassang M, Grimaud A, Cucchi JM, Novellas S, Amoretti N, Chevallier P, et al. Can low-dose computed tomographic scan of the spine replace conventional radiography? An evaluation based on imaging myelomas, bone metastases, and fractures from osteoporosis. Clin Imaging. 2007;31(4):225–7.CrossRefPubMed Chassang M, Grimaud A, Cucchi JM, Novellas S, Amoretti N, Chevallier P, et al. Can low-dose computed tomographic scan of the spine replace conventional radiography? An evaluation based on imaging myelomas, bone metastases, and fractures from osteoporosis. Clin Imaging. 2007;31(4):225–7.CrossRefPubMed
16.
go back to reference Regelink JC, Minnema MC, Terpos E, Kamphuis MH, Raijmakers PG, den Bos IC P-v, et al. Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review. Br J Haematol. 2013;162(1):50–61.CrossRefPubMed Regelink JC, Minnema MC, Terpos E, Kamphuis MH, Raijmakers PG, den Bos IC P-v, et al. Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review. Br J Haematol. 2013;162(1):50–61.CrossRefPubMed
17.
go back to reference Kröpil P, Fenk R, Fritz LB, Blondin D, Kobbe G, Modder U, et al. Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma. Eur Radiol. 2008;18(1):51–8.CrossRefPubMed Kröpil P, Fenk R, Fritz LB, Blondin D, Kobbe G, Modder U, et al. Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma. Eur Radiol. 2008;18(1):51–8.CrossRefPubMed
18.
go back to reference Roodman GD. Skeletal imaging and management of bone disease. Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program. 2008:313–319. Roodman GD. Skeletal imaging and management of bone disease. Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program. 2008:313–319.
19.
go back to reference Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O, et al. A prospective comparison of 18 F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica. 2007;92(1):50–5.CrossRefPubMed Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O, et al. A prospective comparison of 18 F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica. 2007;92(1):50–5.CrossRefPubMed
20.
go back to reference Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R. Value of FDG PET in the assessment of patients with multiple myeloma. AJR Am J Roentgenol. 2005;184(4):1199–204.CrossRefPubMed Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R. Value of FDG PET in the assessment of patients with multiple myeloma. AJR Am J Roentgenol. 2005;184(4):1199–204.CrossRefPubMed
21.
go back to reference Dimopoulos MA, Moulopoulos A, Smith T, Delasalle KB, Alexanian R. Risk of disease progression in asymptomatic multiple myeloma. Am J Med. 1993;94(1):57–61.CrossRefPubMed Dimopoulos MA, Moulopoulos A, Smith T, Delasalle KB, Alexanian R. Risk of disease progression in asymptomatic multiple myeloma. Am J Med. 1993;94(1):57–61.CrossRefPubMed
22.
go back to reference Wisloff F, Andersen P, Andersson TR, Brandt E, Eika C, Fjaestad K, et al. Incidence and follow-up of asymptomatic multiple myeloma. The Myeloma Project of Health Region I in Norway II. Eur J Haematol. 1991;47(5):338–41.CrossRefPubMed Wisloff F, Andersen P, Andersson TR, Brandt E, Eika C, Fjaestad K, et al. Incidence and follow-up of asymptomatic multiple myeloma. The Myeloma Project of Health Region I in Norway II. Eur J Haematol. 1991;47(5):338–41.CrossRefPubMed
23.
go back to reference Lutje S, de Rooy JW, Croockewit S, Koedam E, Oyen WJ, Raymakers RA. Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma. Ann Hematol. 2009;88(12):1161–8.CrossRefPubMedCentralPubMed Lutje S, de Rooy JW, Croockewit S, Koedam E, Oyen WJ, Raymakers RA. Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma. Ann Hematol. 2009;88(12):1161–8.CrossRefPubMedCentralPubMed
24.
go back to reference Hur J, Yoon CS, Ryu YH, Yun MJ, Suh JS. Efficacy of multidetector row computed tomography of the spine in patients with multiple myeloma: comparison with magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography. J Comput Assist Tomogr. 2007;31(3):342–7.CrossRefPubMed Hur J, Yoon CS, Ryu YH, Yun MJ, Suh JS. Efficacy of multidetector row computed tomography of the spine in patients with multiple myeloma: comparison with magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography. J Comput Assist Tomogr. 2007;31(3):342–7.CrossRefPubMed
25.
go back to reference Schulze M, Weisel K, Grandjean C, Oehrlein K, Zago M, Spira D, et al. Increasing bone sclerosis during bortezomib therapy in multiple myeloma patients: results of a reduced-dose whole-body MDCT study. AJR Am J Roentgenol. 2014;202(1):170–9.CrossRefPubMed Schulze M, Weisel K, Grandjean C, Oehrlein K, Zago M, Spira D, et al. Increasing bone sclerosis during bortezomib therapy in multiple myeloma patients: results of a reduced-dose whole-body MDCT study. AJR Am J Roentgenol. 2014;202(1):170–9.CrossRefPubMed
26.
go back to reference Chen YQ, Yang Y, Xing YF, Jiang S, Sun XW. Detection of rib metastases in patients with lung cancer: a comparative study of MRI, CT and bone scintigraphy. PLoS One. 2012;7(12):e52213.CrossRefPubMedCentralPubMed Chen YQ, Yang Y, Xing YF, Jiang S, Sun XW. Detection of rib metastases in patients with lung cancer: a comparative study of MRI, CT and bone scintigraphy. PLoS One. 2012;7(12):e52213.CrossRefPubMedCentralPubMed
Metadata
Title
Improvement of diagnostic confidence for detection of multiple myeloma involvement of the ribs by a new CT software generating rib unfolded images: Comparison with 5- and 1-mm axial images
Authors
Georg Homann
Katja Weisel
Deedar Farhad Mustafa
Hendrik Ditt
Konstantin Nikolaou
Marius Horger
Publication date
01-07-2015
Publisher
Springer Berlin Heidelberg
Published in
Skeletal Radiology / Issue 7/2015
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-015-2131-7

Other articles of this Issue 7/2015

Skeletal Radiology 7/2015 Go to the issue